These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 1808945)
1. [Peripheral and cardiac adaptive mechanisms in heart failure: the role of the renin-angiotensin system and its inhibition]. Drexler H Verh Dtsch Ges Inn Med; 1991; 97():552-7. PubMed ID: 1808945 [No Abstract] [Full Text] [Related]
2. [Growth stimulating properties of angiotensin II on the heart: consequences for therapy of heart failure]. Schunkert H; Holmer SR; Riegger G Z Kardiol; 1993; 82 Suppl 4():1-6. PubMed ID: 8147057 [TBL] [Abstract][Full Text] [Related]
3. [ACE inhibitors in hypertension and heart failure]. Riegger AJ Internist (Berl); 1992 Oct; 33(10):639-44. PubMed ID: 1428682 [No Abstract] [Full Text] [Related]
4. Role of angiotensin-converting enzyme inhibitors in congestive heart failure. Galvao M Heart Lung; 1990 Sep; 19(5 Pt 1):505-11. PubMed ID: 2211159 [TBL] [Abstract][Full Text] [Related]
5. [Angiotensin-converting enzyme inhibitors in the treatment of heart failure: toward a change in the natural history of the disease]. Martín Luengo C; Arribas Jiménez A; Nieto Ballestero F; Diego Domínguez M; Cascón Bueno M; Pabón Osuna P; Sala Sánchez-Castillo A Rev Esp Cardiol; 1993 Mar; 46(3):131-45. PubMed ID: 8488316 [No Abstract] [Full Text] [Related]
6. [ACE inhibition: mechanisms of cardioprotection in chronic experimental heart failure]. Riegger AJ Klin Wochenschr; 1991; 69 Suppl 24():20-3. PubMed ID: 1830909 [TBL] [Abstract][Full Text] [Related]
7. [Angiotensin-converting enzyme (ACE) inhibitors in cardiac decompensation; from randomized study to individual patient]. van Vlies B Ned Tijdschr Geneeskd; 1992 Sep; 136(37):1796-8. PubMed ID: 1407135 [No Abstract] [Full Text] [Related]
8. Neurohormonal activation and the response to converting enzyme inhibitors in congestive heart failure. Kubo SH Circulation; 1990 Feb; 81(2 Suppl):III107-14. PubMed ID: 2137052 [TBL] [Abstract][Full Text] [Related]
10. [Indications for ACE inhibitors in chronic heart failure]. Erdmann E Z Kardiol; 1994; 83 Suppl 4():75-9. PubMed ID: 7856285 [TBL] [Abstract][Full Text] [Related]
11. Which strategy in inhibition of the renin-angiotensin system is the most efficient for heart failure? Ogihara T; Rakugi H J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):184-5. PubMed ID: 18957391 [No Abstract] [Full Text] [Related]
12. [The role of angiotensin converting enzyme inhibition for therapy of patients with hypertension and heart failure]. Hoyen HA; Alpert JS Cardiology; 1993; 82 Suppl 1():3-19. PubMed ID: 8519018 [No Abstract] [Full Text] [Related]
13. The therapeutic role of RAS blockade in chronic heart failure. Werner CM; Böhm M Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):167-77. PubMed ID: 19124420 [TBL] [Abstract][Full Text] [Related]
14. [ACE inhibitors in the treatment of heart failure]. Held P; Swedberg K Nord Med; 1990; 105(8-9):217-8. PubMed ID: 2216686 [TBL] [Abstract][Full Text] [Related]
15. [Treatment with ACE inhibitors until the end of life? Cardiovascular protective mechanisms during blockade of the renin-angiotensin system]. Werner N; Böhm M Dtsch Med Wochenschr; 2004 Jul; 129(27):1513-8. PubMed ID: 15227593 [No Abstract] [Full Text] [Related]
16. Effect of chronic angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic variables in patients with heart failure. Davie AP; Rumley A; Lowe GD; McMurray JJ Thromb Haemost; 2001 Dec; 86(6):1585-6. PubMed ID: 11776334 [No Abstract] [Full Text] [Related]
17. [Rational therapy of heart failure]. Werner MG; Schmieder RE Z Kardiol; 1993; 82 Suppl 4():7-16. PubMed ID: 8147063 [TBL] [Abstract][Full Text] [Related]
18. Medical agents acting on the renin-angiotensin-aldosterone axis for the treatment of heart failure. Kawano H; Node K Hypertens Res; 2010 Mar; 33(3):192-3. PubMed ID: 20203682 [No Abstract] [Full Text] [Related]
19. [Therapy of heart failure with angiotensin converting enzyme inhibitors. Effects on renal function]. Osterziel KJ; Dietz R; Kübler W Dtsch Med Wochenschr; 1989 Jul; 114(27):1082-5. PubMed ID: 2661192 [No Abstract] [Full Text] [Related]
20. The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects. Falkenhahn M; Gohlke P; Paul M; Stoll M; Unger T J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S6-13. PubMed ID: 7898096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]